Literature DB >> 22356681

Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis.

Bruno Dumont1, Vincent Castronovo, Olivier Peulen, Noëlla Blétard, Philippe Clézardin, Philippe Delvenne, Edwin A De Pauw, Andrei Turtoi, Akeila Bellahcène.   

Abstract

The classical fate of metastasizing breast cancer cells is to seed and form secondary colonies in bones. The molecules closely associated with these processes are predominantly present at the cell surface and in the extracellular space, establishing the first contacts with the target tissue. In this study, we had the rare opportunity to analyze a bone metastatic lesion and its corresponding breast primary tumor obtained simultaneously from the same patient. Using mass spectrometry, we undertook a proteomic study on cell surface and extracellular protein-enriched material. We provide a repertoire of significantly modulated proteins, some with yet unknown roles in the bone metastatic process as well as proteins notably involved in cancer cell invasiveness and in bone metabolism. The comparison of these clinical data with those previously obtained using a human osteotropic breast cancer cell line highlighted an overlapping group of proteins. Certain differentially expressed proteins are validated in the present study using immunohistochemistry on a retrospective collection of breast tumors and matched bone metastases. Our exclusive set of selected proteins supports the setup of further investigations on both clinical samples and experimental bone metastasis models that will help to reveal the finely coordinated expression of proteins that favor the development of metastases in the bone microenvironment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356681     DOI: 10.1021/pr201022n

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

Review 1.  Molecular alterations that drive breast cancer metastasis to bone.

Authors:  Penelope D Ottewell; Liam O'Donnell; Ingunn Holen
Journal:  Bonekey Rep       Date:  2015-03-18

2.  A cell-ECM screening method to predict breast cancer metastasis.

Authors:  L E Barney; E C Dandley; L E Jansen; N G Reich; A M Mercurio; S R Peyton
Journal:  Integr Biol (Camb)       Date:  2015-02       Impact factor: 2.192

Review 3.  Matricellular proteins as regulators of cancer metastasis to bone.

Authors:  Timothy N Trotter; Yang Yang
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

4.  Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.

Authors:  Emila Kurbasic; Martin Sjöström; Morten Krogh; Elin Folkesson; Dorthe Grabau; Karin Hansson; Lisa Rydén; Sofia Waldemarson; Peter James; Emma Niméus
Journal:  Clin Proteomics       Date:  2015-05-12       Impact factor: 3.988

5.  CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment.

Authors:  Jules A Westbrook; David A Cairns; Jianhe Peng; Valerie Speirs; Andrew M Hanby; Ingunn Holen; Steven L Wood; Penelope D Ottewell; Helen Marshall; Rosamonde E Banks; Peter J Selby; Robert E Coleman; Janet E Brown
Journal:  J Natl Cancer Inst       Date:  2016-01-12       Impact factor: 13.506

6.  Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.

Authors:  Mengdi Yang; Yi Sun; Jing Sun; Zhiyu Wang; Yiyi Zhou; Guangyu Yao; Yifeng Gu; Huizhen Zhang; Hui Zhao
Journal:  Cancer Med       Date:  2018-03-09       Impact factor: 4.452

7.  Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.

Authors:  Jules A Westbrook; Steven L Wood; David A Cairns; Kathryn McMahon; Renu Gahlaut; Helene Thygesen; Mike Shires; Stephanie Roberts; Helen Marshall; Maria R Oliva; Mark J Dunning; Andrew M Hanby; Peter J Selby; Valerie Speirs; Georgia Mavria; Robert E Coleman; Janet E Brown
Journal:  J Pathol       Date:  2019-01-25       Impact factor: 7.996

8.  Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer.

Authors:  Pamela Maris; Arnaud Blomme; Ana Perez Palacios; Brunella Costanza; Akeila Bellahcène; Elettra Bianchi; Stephanie Gofflot; Pierre Drion; Giovanna Elvi Trombino; Emmanuel Di Valentin; Pino G Cusumano; Sylvie Maweja; Guy Jerusalem; Philippe Delvenne; Eric Lifrange; Vincent Castronovo; Andrei Turtoi
Journal:  PLoS Med       Date:  2015-09-01       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.